BACKGROUND: The aim of the study is to assess the relationship between the shape of plasma glucose concentration during the OGTT and future risk for T2DM. METHODS: 2445 non-diabetic subjects from the Botnia study received an OGTT at baseline and after 7-8 years of follow-up. RESULTS: NGT and IFG subjects who returned their plasma glucose concentration following an ingested glucose load below FPG within 60 min had increased insulin sensitivity, greater insulin secretion and lower risk for future T2DM compared to NGT and IFG subjects whose post-load plasma glucose concentration required 120 min or longer to return their plasma glucose level to FPG level. IGT subjects who had a lower plasma glucose concentration at 1-h compared to 2-h during OGTT had greater insulin sensitivity, better beta cell function and lower risk for future T2DM. CONCLUSIONS: These data suggest that the shape of glucose curve can be utilized to assess future risk for T2DM.
BACKGROUND: The aim of the study is to assess the relationship between the shape of plasma glucose concentration during the OGTT and future risk for T2DM. METHODS: 2445 non-diabetic subjects from the Botnia study received an OGTT at baseline and after 7-8 years of follow-up. RESULTS: NGT and IFG subjects who returned their plasma glucose concentration following an ingested glucose load below FPG within 60 min had increased insulin sensitivity, greater insulin secretion and lower risk for future T2DM compared to NGT and IFG subjects whose post-load plasma glucose concentration required 120 min or longer to return their plasma glucose level to FPG level. IGT subjects who had a lower plasma glucose concentration at 1-h compared to 2-h during OGTT had greater insulin sensitivity, better beta cell function and lower risk for future T2DM. CONCLUSIONS: These data suggest that the shape of glucose curve can be utilized to assess future risk for T2DM.
Authors: Heba M Ismail; Ping Xu; Ingrid M Libman; Dorothy J Becker; Jennifer B Marks; Jay S Skyler; Jerry P Palmer; Jay M Sosenko Journal: Diabetologia Date: 2017-09-27 Impact factor: 10.122
Authors: Adam Hulman; Rebecca K Simmons; Dorte Vistisen; Adam G Tabák; Jacqueline M Dekker; Marjan Alssema; Femke Rutters; Anitra D M Koopman; Thomas P J Solomon; John P Kirwan; Torben Hansen; Anna Jonsson; Anette Prior Gjesing; Hans Eiberg; Arne Astrup; Oluf Pedersen; Thorkild I A Sørensen; Daniel R Witte; Kristine Færch Journal: Endocrine Date: 2016-10-03 Impact factor: 3.633
Authors: Diedre Winner; Luke Norton; Mustafa Kanat; Ruth Arya; Marcel Fourcaudot; Andrea Hansis-Diarte; Devjit Tripathy; Ralph A DeFronzo; Christopher P Jenkinson; Muhammad Abdul-Ghani Journal: J Clin Endocrinol Metab Date: 2014-05-05 Impact factor: 5.958
Authors: Akram Alyass; Peter Almgren; Mikael Akerlund; Jonathan Dushoff; Bo Isomaa; Peter Nilsson; Tiinamaija Tuomi; Valeriya Lyssenko; Leif Groop; David Meyre Journal: Diabetologia Date: 2014-10-08 Impact factor: 10.122
Authors: Caroline K Kramer; Chang Ye; Anthony J G Hanley; Philip W Connelly; Mathew Sermer; Bernard Zinman; Ravi Retnakaran Journal: Diabetologia Date: 2015-03-12 Impact factor: 10.122
Authors: Silva Arslanian; Laure El Ghormli; Joon Young Kim; Fida Bacha; Christine Chan; Heba M Ismail; Lorraine E Levitt Katz; Lynne Levitsky; Jeanie B Tryggestad; Neil H White Journal: Diabetes Care Date: 2018-11-19 Impact factor: 19.112